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Abstract:  This study attempted to prove our hypothesis that a short-term toxicity study, using a 4-day dosing regimen
as an example, is suitable for evaluating myelotoxicity in rats.  We compared the hematological, bone marrow
cytological and histopathological results of 5-fluorouracil (5-FU) treated and pair-feeding groups after a 4-day
administration period.  Several experimental groups were defined for this 4-day study as well as for our previously
reported 14-day study (Miyata et al., 2009); these included 5-FU treated groups receiving 12, 15 and 18 mg/kg/day
(FU12, FU15 and FU18), pair-feeding groups (R12, R15 and R18 receiving the same amount of food as the FU12, FU15
and FU18 groups, respectively) and a nontreated control group.  Although severe reductions in body weight gain and
food consumption were reported in the 14-day study, only slight reductions were observed in the 4-day study.  In the 4-
day study, a decrease in blood reticulocytes and a decreasing trend of marrow erythroid cells were only observed in the
FU18 group, and no effects were observed in the pair-feeding groups.  The erythroblastic changes observed in this 4-
day study were thought to reflect the direct influence of 5-FU administration.  Since concerns regarding the influence
of secondary changes related to undernutrition were minimized in the 4-day study, it was thought to clarify the direct
influence of 5-FU administration on erythroblastic cells.  Thus, a 4-day study protocol might be helpful for distinguishing
secondary changes related to undernutrition.   (J Toxicol Pathol 2010; 23: 31–37)
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Introduction 
The rat is a widely used animal model for safety
assessments of such things as pharmaceuticals.  Dietary
restriction is currently one of the most effective methods for
extending the lifespan of rodents and delaying the onset of
age-related diseases1–3.  Meanwhile, many reports
concerning hematological changes in dietary restricted rats
have been published4–9.  Young rats exhibiting remarkable
growth are generally used in short-term repeated-dose
toxicity studies, and suppression of body weight gain and
decreased food consumption are often recognized in the drug
administration groups in such toxicity studies.
Consequently, whether hematological, bone marrow
cytological or histopathological changes are caused directly
by the drug being tested or indirectly by suppression of body
weight gain and decreased food consumption can be difficult
to evaluate.  We previously reported that many of the
influences of dietary restriction on hematological
examination values were comparable to those caused by 5-
fluorouracil (5-FU) administration for 14 days in young rats
(6 weeks old at the start of experimentation)10.  Furthermore,
we also reported that adult rats (12 weeks old at the start of
experimentation) with a minimal body weight gain were
more suitable than young rats for hematological evaluations
in a 14-day study period11.  However, the age-related
differences between the young and adult studies were not
very large, possibly because these age groups were rather
close.  Thus, we suspected that further rat studies were
needed to evaluate myelotoxicity.  Though a 14-day period
was selected in our previous studies, we hypothesized that a
shorter period, such as 4 days, might be useful for evaluating
myelotoxicity, since the influence of undernutrition would
be reduced.
The anti-cancer drug 5-FU belongs to a category of
chemotherapy agents called antimetabolites and functions as
a pyrimidine analog12, 13; the myelotoxic effect of 5-FU on
the bone marrow is a serious adverse effect associated with
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its clinical use14.  DNA and RNA synthesis is inhibited by 5-
FU not only after repeated dosing, but also after single
dosing15.  In this study, we selected 5-FU as a positive
control for myelotoxicity.
In the present study, 5-FU treated and pair-feeding
groups (animals that were given the same amount of food as
the average amount of food consumed by the 5-FU treated
animals) were used.  We compared the hematological, bone
marrow cytological and histopathological results of the 5-FU
treated and pair-feeding groups after a 4-day administration
period.  Here, we discuss the differences in the
hematological and/or myelotoxic effects under decreased
food consumption based on the common general toxic
parameters.  Our hypothesis that a 4-day period may be
suitable for evaluating myelotoxicity was verified by
referring to our previous 14-day study results.
Materials and Methods
Chemicals and dose selection rationale
The 5-FU was purchased from Wako Pure Chemical
Industries Ltd.  (Osaka, Japan) and was dissolved in water
for injection for dosing.  Since this 4-day study was a
comparative experiment, the same dosages as used in our
previous 14-day study10 were chosen; therefore, dosages of
12, 15 and 18 mg/kg/day were selected.
Animals and housing conditions
A total of 42 male Crl:CD(SD) rats were purchased
from Charles River Japan, Inc.  (Tsukuba, Ibaraki, Japan).
The animals were housed individually in stainless steel cages
(W:225 mm × D:350 mm × H:200 mm) with an artificial
lighting cycle of 12 hours (7:15 to 19:15), a temperature of
23 ± 3°C, a relative humidity of 50 ± 20% and a ventilation
cycle of 10 to 20 times/hour.  Before group assignment, all
the animals were allowed free access to a standard laboratory
animal chow (MF; Oriental Yeast Co., Ltd., Tokyo, Japan)
and drinking water.  After group assignment, the R12, R15
and R18 groups described below were given restricted diets.
At the start of dosing and pair-feeding, the animals were 6
weeks of age.
All the animals were treated in accordance with the
recommendations of the Guide for the Care and Use of
Laboratory Animals of Taisho Pharmaceutical Co., Ltd.
Study groups
The animals were divided into the following 7 groups:
NT, FU12, FU15, FU18, R12, R15 and R18 (6 rats/group).
The animals in the NT group were nontreated and were
allowed free access to a standard laboratory animal chow;
this group was used as the control group.  The animals in the
FU12, FU15 and FU18 groups were orally treated with 5-FU
for 4 consecutive days at doses of 12, 15 and 18 mg/kg,
respectively.  The dose volume was set at 10 mL/kg body
weight and was calculated based on the most recent body
weight.  The animals in the R12, R15 and R18 groups were
not given 5-FU, but were given amounts of food equal to
those consumed by the rats in the FU12, FU15 and FU18
groups, respectively.  If all the food was not consumed in any
of the R12, R15 or R18 groups, the next allotment of chow
was supplied without removing the food that had not been
consumed.  The next day of initial administration of 5-FU
was set as the start date of pair-feeding.
Examinations and methods
The starting day of 5-FU administration or pair-feeding
was designated as Day 0 in this study.  Body weight and food
consumption were measured every day in each animal.  The
ratio of the amount of limited food was calculated using the
following formula: fu / nt -100, where fu represents the total
amount of food consumption in each 5-FU group × 100 and
nt represents the total amount of food consumption in the NT
group.  The animals were fasted for at least 16 hours prior to
necropsy, and blood samples were collected via the
abdominal aorta under ether anesthesia into dipotassium
ethylenediaminetetraacetic acid (EDTA-2K) treated tubes
for hematological examination.  The complete blood count
(CBC) and differential white blood cell count were measured
using a hematology analyzer (Technicon H·1E; Bayer
Medical Ltd., Tarrytown, NY, USA).  The percentage of
reticulocytes was measured using a flow cytometer (EPICS-
XL; Beckman Coulter Inc., Fullerton, CA, USA) with
coriphosphine-O stain.  After blood sampling, all the animals
were euthanized by exsanguination.  For the marrow
cytological evaluation, the right-side femur was obtained
and used.  The bone marrow nucleated cell count was
measured using the above-mentioned hematology analyzer.
The differential cell count was determined by counting 500
cells in bone marrow smears stained with May-Grünwald
and Giemsa.  Then, the absolute numbers of each type of
marrow cell (myeloid, erythroid, lymphoid and other cells)
were calculated using the data for the marrow cell number
and marrow differential counts.  The spleen and thymus were
weighed, and the ratios of these organ weights to the body
weight (relative weight) were calculated based on the final
body weight.  For the histopathological evaluation, the left-
side femur (bone marrow), liver, spleen, kidney, thymus,
adrenal, stomach, duodenum, ileum and colon were fixed in
10% neutral buffered formalin.  The femur was decalcified
using the Plank-Rychlo method.  After fixation, hematoxylin
and eosin (H&E) stained specimens were prepared and
subjected to microscopic observation.
Statistical analysis
Significant differences between the NT and 5-FU
treated groups or between the NT and pair-feeding groups
were analyzed using the following procedure.  The
homogeneity of the variance among the groups was first
tested using a Bartlett’s test.  When a homogenous variance
was noted, all the groups were compared using a one-way
analysis of variance.  When a heterogeneous variance was
noted, the Kruskal-Wallis test was subsequently performed.
Finally, the Dunnett’s test (if homogeneous) or Dunnett’s-
type multiple comparison test (if heterogeneous) was used ifAsanuma, Miyata, Iwaki et al. 33
a significant difference was noted between the groups.
Significant differences between the 5-FU treated and
pair-feeding groups (i.e., FU12 vs. R12, FU15 vs. R15 or
FU18 vs. R18) were analyzed using the following procedure.
The homogeneity of the variance among the groups was first
tested using the F-test, and then the Student’s t-test (if
homogeneous) or Aspin-Welch’s t-test (if heterogeneous)
was performed.
The Bartlett’s test, one-way analysis of variance,
Kruskal-Wallis test and F-test were conducted using a
significance level of 5% (two-tailed), while the other tests
were conducted using significance levels of 1% and 5%
(two-tailed).  Statistical analyses of the clinical observations
and necropsy and histopathology results were not performed.
Results
Mortality and clinical signs
No deaths and no abnormalities were seen in the present
4-day study.
Food consumption and body weight
In the 5-FU treated groups, a decrease in food
consumption was seen at the end of the administration
period.  The ratios of the total amount of food consumption
in each 5-FU treated group (FU12, FU15 and FU18),
compared with the NT group, were –8%, –7% and –11%,
respectively (Fig. 1A).  In the pair-feeding groups, one rat
left some food on Day 2 but subsequently consumed all the
available food thereafter.
Body weight in the FU18 group was lowest at the end of
the administration period, but it was not a marked change
since it was only less than 10% compared with the
corresponding NT group.  No statistically significant
difference was observed between the 5-FU treated and pair-
feeding groups (Fig. 1B).
Hematology and bone marrow cytology
The principal results are shown in Figs. 2 and 3.  In the
hematological analysis of the peripheral blood samples, a
statistically significant decrease in the number of
reticulocytes was observed in the FU18 group (Fig. 2A).  In
the bone marrow analysis, a decreasing trend of erythroid
cells was observed in the FU18 group, although this change
was not statistically significant (Fig. 3A).  Meanwhile, no
effects were observed in the pair-feeding groups in the 4-day
study.  Individual data regarding the numbers of blood
reticulocytes and marrow erythroid cells in the FU18 group
are shown in Fig. 4.  Decreases in the numbers of these cells
were particularly remarkable in 2 of the 6 rats.  In addition,
abnormal granulocytes with hypersegmented nuclei and/or
polyploidy nuclei (with a frequency of 1% or less) were
observed in one rat in the FU18 group.  This rat was one of
the two rats that exhibited remarkable decreases in the
numbers of reticulocytes and erythroid cells, as mentioned
above.  A statistically significant difference in the number of
marrow lymphoid cells was observed between the 5-FU
treated and pair-feeding groups, but this change was not
meaningful, as it was within the physiological range (Fig.
3C). 
Organ weight
A decrease in the thymus weight was observed in the
FU18 group (Fig. 5A).  No change was observed in the
spleen weight (Fig. 5B).
Necropsy and histopathology
No abnormalities were seen in either the macroscopical
or microscopical examinations performed in all the groups.
Representative tissue images of the bone marrow are shown
in Fig. 6.
Discussion
We compared the hematological, bone marrow
cytological and histopathological results of the 5-FU treated
and pair-feeding groups after a 4-day administration period.
Differences between the present study data (4-day period)
and previously reported study data (14-day period)10 were
then compared.
Although severe reductions in body weight and food
consumption were reported in the 14-day study, only slight
reductions were observed in the present 4-day study.  A
decrease in the numbers of blood reticulocytes and a
decreasing trend of marrow erythroid cells were observed in
the FU18 group in the 4-day study.  Furthermore, the
decreases in the numbers of these cells were particularly
remarkable in 2 of the 6 rats.  Meanwhile, no effects were
observed in the pair-feeding groups in this 4-day study.  On
the other hand, no differences in these decreases of the
erythroblastic cells were found in the 5-FU treated or pair-
feeding groups in the 14-day study due to severe
undernutrition10.  The erythroblastic changes observed in
Fig. 1. Food consumption and body weight changes during the
administration period.  Data are expressed as percentages
relative to the NT group and were calculated using the mean
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this 4-day study were thought to reflect the direct influence
of 5-FU administration.  Ogawa et al. reported that dietary
restriction strongly influences the reticulocytes in peripheral
blood5.  We previously reported that the influence of
undernutrition on erythroblastic changes cannot be
disregarded in 14-day toxicity studies10, 11.  Moreover, the
susceptibility of plasma erythropoietin levels to feeding
conditions16 originates from the decrease in the dietary
protein content17–19.  We considered that undernutrition,
especially a reduction in dietary protein, might also result in
a decrease in blood reticulocytes and marrow erythroid cells.
Since the influence of secondary changes related to
undernutrition was reduced in the 4-day study, it was thought
to clarify the direct influence of 5-FU administration on
erythroblastic cells.  Thus, evaluations performed at a time
when the influence of undernutrition had not yet appeared
were useful for evaluating the erythroblastic cells.  In
addition, the direct influence of 5-FU administration was
also detected in the marrow cytological examination
performed in the 4-day study.  Abnormal granulocytes with
hypersegmented nuclei and/or polyploidy nuclei (with a
frequency of 1% or less) were observed in one rat in the
FU18 group; however, a reduction in myelo-lymphoid cells
was not observed.  Though those changes were diminutive,
but they were considered the effects of 5-FU based on our
previous 14-day study results.  These cytological anomalies
were not observed in any of the nontreated and pair-feeding
regimens in our previous studies10, 11.  The administration
period might be short in dosage used in this 4-day study so
that marrow cytological change may change clearly.  The
number of reticulocytes is larger in rats than in dogs or
monkeys20, 21; thus, rats appear to exhibit erythrokinetic
activity.  This fact might explain the difference in cytopenia
receptivity.  In this 4-day study, no histopathological
changes were detected, though telangiectasis and decreased
hematopoiesis in bone marrow were reported in the previous
14-day study10.  The above pathological differences between
the two studies were likely due to the short dosing period,
low dosage of 5-FU and small influence of undernutrition in
the 4-day study.
Fig. 2. Hematological changes in reticulocytes (A), red blood
cells (B), hemoglobin (C), platelets (D) and white blood
cells (E) at the end of the administration period.  Data are
expressed as means ± S.D. (n=6).  Statistical significance
was analyzed using the Dunnett’s test or Dunnett’s-type
test (**p<0.01), compared with the NT group.
Moreover, the differences in values between the 5-FU
treated and pair-feeding groups were analyzed using a
Student’s t-test or Aspin-Welch’s t-test (# p<0.05).Asanuma, Miyata, Iwaki et al. 35
Matsumoto et al. reported that 4-day toxicity studies are
effective based on the total generation time of marrow
cells22, and the occurrence of hemocytopenia is seen within
about 4 days in tests for several myelotoxic chemicals22–25.
Since examinations performed within a 4-day period are not
yet influenced by undernutrition, the influence of 5-FU on
erythroblastic cells was successfully detected in our 4-day
study.  The pair-feeding examination performed in the
present study also suggested that the 4-day toxicity study
was useful for detecting 5-FU toxicity.  Nonspecific stress
responses commonly lead to erroneous identification of test
compounds as immuno-myelotoxic.  In conclusion, in
repeated-dose toxicity studies of drugs in rats, weight loss
and decreased food consumption are often recognized in
drug administration groups.  Consequently, 4-day toxicity
studies for hematological evaluations might be helpful for
distinguishing secondary changes arising from
undernutrition.
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